GALAPAGOS
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
GALAPAGOS
Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical
Founded:
1999-01-01
Address:
Mechelen-bovelingen, Limburg, Belgium
Country:
Belgium
Website Url:
http://www.glpg.com
Total Employee:
251+
Status:
Active
Contact:
+32 15 34 29 00
Email Addresses:
[email protected]
Total Funding:
5.45 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-06-21 | CellPoint | CellPoint acquired by Galapagos | 125 M EUR |
2021-06-21 | Abound Bio | Abound Bio acquired by Galapagos | 14 M USD |
2013-01-15 | Cangenix | Cangenix acquired by Galapagos | N/A |
2010-02-02 | Argenta Discovery | Argenta Discovery acquired by Galapagos | N/A |
2007-01-02 | ProStrakan | ProStrakan acquired by Galapagos | 31 M EUR |
2006-12-07 | Inpharmatica | Inpharmatica acquired by Galapagos | 19.1 M EUR |
2005-09-21 | BioFocus DPI | BioFocus DPI acquired by Galapagos | 36.5 M USD |
Investors List
Gilead Sciences
Gilead Sciences investment in Post-IPO Equity - Galapagos
University of Antwerp
University of Antwerp investment in Grant - Galapagos
Van Herk Ventures
Van Herk Ventures investment in Post-IPO Equity - Galapagos
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos
Thuja Capital
Thuja Capital investment in Venture Round - Galapagos
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos
Gilde Healthcare
Gilde Healthcare investment in Venture Round - Galapagos
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2013-07-01 | Vitalnext | Galapagos investment in Funding Round - Vitalnext | N/A |
Key Employee Changes
Date | New article |
---|---|
2022-01-26 | Galapagos appoints Paul Stoffels as Chief Executive Officer |
Official Site Inspections
http://www.glpg.com Semrush global rank: 39.37 K Semrush visits lastest month: 3.28 M
- Host name: s3-website-eu-west-1.amazonaws.com
- IP address: 52.92.36.148
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Galapagos"
Organization, structure and operation - Galapagos NV Annual โฆ
Risks related to our organization, structure and operation Continuous required successful attracting and retaining qualified personnel Our future success depends on our ability to retain โฆSee details»
Organization, structure and operation - Galapagos โฆ
Risks related to our organization, structure and operation. Risk factors CSR report. Galapagos NV โข Annual Report 2018. Our future success depends on our ability to retain the members of our executive committee and to attract, retain โฆSee details»
Organization, structure and operation - Galapagos โฆ
Organization, structure and operation. CSR report. Galapagos NV โข Annual Report 2019. Our future success depends on our ability to retain the members of our executive committee and to attract, retain and motivate qualified โฆSee details»
Living Innovation - glpg.com
Indications. We have built an organization based Pioneering for patients Diversifying and accelerating our pipeline Partnering for greater impact Making it happen, together, as a team โฆSee details»
Galapagos announces full year 2023 results and outlook for 2024
Dec 31, 2023 Webcast presentation tomorrow, 23 February 2024, at 14:00 CET / 8:00 am ET, www.glpg.com. Mechelen, Belgium; 22 February 2024, 22:01 CET; regulated information โ โฆSee details»
Galapagos - LinkedIn
Galapagos | 74,808 followers on LinkedIn. We are a biotechnology company with operations in Europe and the U.S. dedicated to developing transformational medicines for more years of life and ...See details»
Board of Directors - Galapagos
Corporate Governance. Our commitment to Corporate Governance. We believe in transparency, accountability, and ethical leadership. To learn more about our corporate governance principles, our board of directors, and our dedication to โฆSee details»
The Global LPG Partnership
The GLPGP Mission: Assist developing countries and their stakeholders to plan, finance and implement the appropriate, evidence-based, national-scale availability and use of LPG โฆSee details»
Organization, structure and operation - Galapagos Annual Report โฆ
Organization, structure and operation. CSR report. Galapagos NV โข Annual Report 2020. Our future success depends on our ability to retain the members of our management board and to โฆSee details»
Galapagos enters into strategic collaboration agreement
Jan 4, 2024 Media inquiries: Marieke Vermeersch +32 479 490 603 [email protected] : Investor inquiries: Sofie Van Gijsel +1 781 296 1143 [email protected] Sandra CauwenberghsSee details»
Our story - Galapagos
June. Galapagos announced the acquisition of CellPoint and AboundBio, propelling Galapagos into next-generation cell therapy while significantly broadening its portfolio and โฆSee details»
What We Do - The Global LPG Partnership
At GLPGP, we: Create national LPG and bio-LPG plans. GLPGP partners with host country governments and other stakeholders to create national plans for rapid, sustainable scale-up of โฆSee details»
Organization, structure and operation - Galapagos NV Annual โฆ
Risks related to our organization, structure and operation Our future success depends on our ability to retain the members of our management board and to attract, retain and motivate โฆSee details»
Executive Committee - Galapagos NV Annual Report 2022
Dec 31, 2022 He joined Galapagos in September 2017 as Senior Vice President Commercial Operations to build and lead Galapagosโ commercial organization and capabilities. Previously, โฆSee details»
Our organization | Who we are | Home - bp
Our organization. bp has three main businesses โ production & operations, gas & low carbon energy and customers & products โ enabled by trading & shipping. Production & operations โฆSee details»
Corporate Governance Charter - glpg.com
Page 2 of 23 Introduction This corporate governance charter (the โCharterโ) supplements the corporate governance terms set forth in the Code of Companies and Associations and the โฆSee details»
Our Sustainability Governance - Galapagos NV Annual Report 2022
We value our planet and take initiatives to safeguard the environment and incorporate greener practices across our organization Development. All activities required to bring a new drug to โฆSee details»
People - Galapagos
As we actively seek to develop a diverse and inclusive workplace, we aim to define a roadmap to achieve our goal of being a more diverse, equitable and inclusive organization by 2028 and to โฆSee details»